Additional file 2 of Proteomics-based identification of TMED9 is linked to vascular invasion and poor prognoses in patients with hepatocellular carcinoma

  • Ming Huang Chen (Creator)
  • Wei-Min Chang (Creator)
  • Shih Ming Jung (Contributor)
  • Chun Nan Yeh (Creator)
  • Min Che Tung (Contributor)
  • Ming-Hsien Chien (Creator)
  • Yi Hua Jan (Creator)
  • Yi Chieh Yang (Contributor)
  • Michael Hsiao (Creator)
  • Tsung Ching Lai (Contributor)



Additional file 2: Figure S1. Expression of TMED9 transcripts in paired adjacent (GSE76311, probe: TC05001018.hg.1; a and unpaired normal and tumor tissues (GSE102079, probe: 208757_at; b derived from patients with hepatocellular carcinoma (HCC). Figure S2. TMED9 overexpression promotes cell growth and migration of HCC36 cells. a HCC36 cells were infected with a lentivirus carrying control vector or HA-TMED9. After 72 h, the expression of TMED9 was determined by Western blotting. b, c Cell-proliferative b and migratory c abilities of HCC36 cells expressing control vector or HA-TMED9. Values are presented as the mean ± SD from three independent experiments. *p